LL-37 (37-1) 是 LL-37 (HY-P1222) 的反向序列,其生物活性与 LL-37 高度相似。LL-37 (37-1) 具有杀菌功能,是一种免疫系统宿主防御肽。LL-37 (37-1) 可通过与双链 RNA (dsRNA) 相互作用,抑制双链 RNA 诱导的胸腺基质淋巴细胞生成素、CCL5/RANTES、CXCL10/IP-10 和 CXCL8/IL-8 的产生,并上调 CXCL8 的表达。LL-37 (37-1) 可用于银屑病、特应性皮炎的相关研究。
产品信息
| 产品名称 | LL-37 (37-1) |
| 产品描述 | LL-37 (37-1) is the reverse sequence of LL-37 (HY-P1222), with biological activity highly similar to that of LL-37. LL-37 (37-1) has bactericidal function and is a host defense peptide of the immune system. LL-37 (37-1) can interact with double-stranded RNA (dsRNA) to inhibit double-stranded RNA-induced production of thymic stromal lymphopoietin, CCL5/RANTES, CXCL10/IP-10, and CXCL8/IL-8, and upregulate the expression of CXCL8. LL-37 (37-1) can be used in research on psoriasis and atopic dermatitis. |
| 生物活性 | LL-37 (37-1) is the reverse sequence of LL-37 (HY-P1222), with biological activity highly similar to that of LL-37. LL-37 (37-1) has bactericidal activity and acts as an immune system host defense peptide. LL-37 (37-1) inhibits double-stranded RNA (dsRNA)-induced production of thymic stromal lymphopoietin, CCL5/RANTES, CXCL10/IP-10 and CXCL8/IL-8, and upregulates the expression of CXCL8 via interaction with dsRNA. LL-37 (37-1) can be used in research related to psoriasis and atopic dermatitis. |
| 分子式 | C205H340N60O53 |
| CAS号 | 2022972-70-7 |
| 序列 | Ser-Glu-Thr-Arg-Pro-Val-Leu-Asn-Arg-Leu-Phe-Asp-Lys-Ile-Arg-Gln-Val-Ile-Arg-Lys-Phe-Glu-Lys-Gly-Ile-Lys-Glu-Lys-Ser-Lys-Arg-Phe-Phe-Asp-Gly-Leu-Leu |
| 序列缩写 | SETRPVLNRLFDKIRQVIRKFEKGIKEKSKRFFDGLL |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |


联系我们